NasdaqGM - Nasdaq Real Time Price • USD Cronos Group Inc. (CRON) Follow Compare 1.9800 -0.0500 (-2.46%) At close: 4:00:02 PM EST 1.9700 -0.01 (-0.51%) After hours: 4:34:49 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Cronos Group Inc. (CRON): Among the Best CBD Stocks to Invest In Right Now We recently published a list of 7 Best CBD Stocks To Invest In Right Now. In this article, we are going to take a look at where Cronos Group Inc. (NASDAQ:CRON) stands against other best CBD stocks to invest in right now. An essential component of medical marijuana, CBD is the legal, non-psychoactive compound that […] Is Cronos Group (CRON) One of the Best Long-Term Penny Stocks to Buy According to Hedge Funds? We recently published a list of the 12 Best Long-Term Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Cronos Group Inc. (NASDAQ:CRON) stands against the other best long-term penny stocks to buy. What’s the Future Like for Small Cap Stocks in 2025? On […] Is Cronos Group Inc. (CRON) the Best Marijuana Stock to Buy According to Hedge Funds? We recently compiled a list of the 10 Best Marijuana Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Cronos Group Inc. (NASDAQ:CRON) stands against the other marijuana stocks. The United States of America is the country that consumes the most weed in the world. As […] 3 Penny Stocks On TSX With Market Caps Below CA$2B The Canadian market has experienced a pullback recently, with the TSX index declining by about 6.5% since its peak in December, amid political uncertainty and potential shifts in government leadership. Despite this volatility, long-term investors may find opportunities to explore smaller companies that offer growth potential and financial stability. Penny stocks, though an outdated term, remain relevant as they often represent emerging companies that could provide value for those willing to... Why Cronos Group (CRON) Is Among the Best Cannabis Stocks To Invest In? We recently compiled a list of the 11 Best Cannabis Stocks To Invest In. In this article, we are going to take a look at where Cronos Group Inc. (NASDAQ:CRON) stands against the other best cannabis stocks to invest in. The history of cannabis cultivation in America dates back to the early colonists, who grew […] Cronos Group And 2 Other TSX Penny Stocks To Consider The Canadian stock market is experiencing strong momentum heading into 2025, supported by a resilient consumer base and rising corporate profits. Amidst this positive backdrop, investors may find value in exploring penny stocks, which despite their historical connotations, can offer significant opportunities. By focusing on those with robust financials and growth potential, investors might uncover hidden value in smaller companies with promising prospects. Cronos Group Inc. (CRON): A Bull Case Theory We came across a bullish thesis on Cronos Group Inc. (CRON) on Raging Bull Investments’ Substack by Jake LaMotta. In this article, we will summarize the bulls’ thesis on CRON. Cronos Group Inc. (CRON)’s share was trading at $2.01 as of Nov 15th. CRON’s trailing P/E was 65.31 according to Yahoo Finance. Cronos Group presents a compelling […] Cronos Group Third Quarter 2024 Earnings: Beats Expectations Cronos Group ( TSE:CRON ) Third Quarter 2024 Results Key Financial Results Revenue: US$34.3m (up 38% from 3Q 2023). Net... Cronos Group Inc (CRON) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic ... Cronos Group Inc (CRON) reports significant revenue growth and improved cash flow, while navigating competitive pressures and regulatory uncertainties. Why Cronos Group Stock Popped 9% Today Cronos stock just went up -- a lot. Maybe it's time to sell? Cronos Group (CRON) Q3 2024 Earnings Call Transcript CRON earnings call for the period ending September 30, 2024. Cronos: Q3 Earnings Snapshot STAYNER, Ontario (AP) — Cronos Group Inc. CRON) on Tuesday reported profit of $8.3 million in its third quarter. On a per-share basis, the Stayner, Ontario-based company said it had profit of 2 cents. Cronos Group Up 7.6% In US Premarket as Swings to Q3 Profit Cronos Group Up 7.6% In US Premarket as Swings to Q3 Profit Cronos Group Reports 2024 Third Quarter Results Net revenue in Q3 2024 increased by 38% year-over-year to $34.3 million Spinach® Becomes the Number One Cannabis Brand in Canada1 Industry-leading balance sheet with $862 million in cash and cash equivalents TORONTO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced its 2024 third quarter business results. “Our results this quarter demonstrate that our long-term strategy is working. With record net revenue and a disciplined Cannabis stocks fall: FL voters reject legalizing recreational use Cannabis stocks, like Curaleaf (CURLF), Trulieve (TCNNF), Canopy (CGC), Tilray (TLRY), and Cronos (CRON), have fallen after Florida voters rejected a measure to legalize recreational marijuana. Market Domination Hosts Julie Hyman and Josh Lipton examine what the market moves mean. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Naomi Buchanan. Zacks.com featured highlights include Amneal Pharmaceuticals, Cronos Group, Carriage Services, Business First Bancshares and Amphenol Amneal Pharmaceuticals, Cronos Group, Carriage Services, Business First Bancshares and Amphenol are part of the Zacks Screen of the Week article. 5 Stocks Backed by High Efficiency for Solid Gains Amid Volatility Invest in stocks of AMRX, CRON, CSV, BFST and APH to tap their high-efficiency levels. Election 2024: Harris, Trump agree on cannabis policy The US presidential election is on the horizon. While Vice President Harris and former President Donald Trump differ on many issues, they share common ground on cannabis reform. Poseidon co-founder Emily Paxhia joins Market Domination Overtime to analyze this development. "I think it's finally showing how the electorate's will to see cannabis as a legal resource in the United States is finally reaching the lawmakers and at the highest level of the executive branch in this instance," she explains. Despite this political alignment, cannabis stocks have shown little movement. Paxhia attributes this to "a structural issue around being able to trade in the US" due to custody limitations. She suggests banking reform could resolve this barrier, potentially increasing investor access to cannabis stocks. For more insights on bipartisan support for cannabis reform and regulation, watch the full interview above. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Angel Smith Cronos Group Inc. to Hold 2024 Third Quarter Earnings Conference Call on November 12, 2024 TORONTO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 third quarter earnings conference call on Tuesday, November 12, 2024 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/ev Spotlight On TSX Penny Stocks For October 2024 Over the last 7 days, the Canadian market has risen by 1.0%, and over the past year, it is up by an impressive 27%. Investing in penny stocks—though a somewhat outdated term—can still provide access to growth opportunities, especially in smaller or newer companies. These stocks can offer significant value when backed by strong financial health, and we'll explore several that might pair balance sheet strength with long-term potential. Performance Overview Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index Return CRON S&P/TSX Composite index YTD +1.54% +0.60% 1-Year -4.81% +18.10% 3-Year -49.23% +17.47%